Lorraine V. Kalia

60 Leonard Avenue
Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 118 publications

Co- and multipathologies need serious consideration for understanding Parkinson's disease pathogenesis and designing novel experimental therapeutic strategies.

Co- and multipathologies need serious consideration for understanding Parkinson's disease pathogenesis and designing novel experimental therapeutic strategies.

Journal: Journal of Parkinson's disease
Published: September 08, 2026

The road towards faster development of novel pharmacotherapies for persons with Parkinson's disease.

The road towards faster development of novel pharmacotherapies for persons with Parkinson's disease.

Journal: Journal of Parkinson's disease
Published: July 03, 2026

Phase 2 Futility Trials in Alzheimer Disease and Mild Cognitive Impairment: A Cohort Analysis of the ADNI Data Set.

Phase 2 Futility Trials in Alzheimer Disease and Mild Cognitive Impairment: A Cohort Analysis of the ADNI Data Set.

Journal: Neurology
Published: June 18, 2026

Deep brain stimulation in alpha-synuclein models of Parkinson's disease: Bridging the translational gap.

Deep brain stimulation in alpha-synuclein models of Parkinson's disease: Bridging the translational gap.

Journal: Journal of Parkinson's disease
Published: June 16, 2026

Georgina M. Aldridge, Matthew Weber and Lauren Walker recipients of the Parkinson Prize 2025.

Georgina M. Aldridge, Matthew Weber and Lauren Walker recipients of the Parkinson Prize 2025.

Journal: Journal of Parkinson's disease
Published: June 05, 2026

Levodopa and Melanoma: Practical Recommendations for Parkinson's Disease-International Parkinson and Movement Disorder Society Scientific Issues Committee Viewpoint.

Levodopa and Melanoma: Practical Recommendations for Parkinson's Disease-International Parkinson and Movement Disorder Society Scientific Issues Committee Viewpoint.

Journal: Movement disorders clinical practice
Published: May 28, 2026

Modulating α-synuclein clearance: a comparison of high-frequency and direct current stimulation in preclinical models of Parkinson's disease.

Modulating α-synuclein clearance: a comparison of high-frequency and direct current stimulation in preclinical models of Parkinson's disease.

Journal: Brain communications
Published: April 10, 2026

Georgina M. Aldridge, Matthew Weber and Lauren Walker recipients of the Parkinson Prize 2025.

Georgina M. Aldridge, Matthew Weber and Lauren Walker recipients of the Parkinson Prize 2025.

Journal: Journal of Parkinson's disease
Published: February 05, 2026

Co- and Multi-Pathologies in Parkinson's Disease: An International Parkinson and Movement Disorder Society Scientific Issues Committee Review.

Co- and Multi-Pathologies in Parkinson's Disease: An International Parkinson and Movement Disorder Society Scientific Issues Committee Review.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: February 04, 2026

Bridging global diversity gaps in Parkinson disease research.

Bridging global diversity gaps in Parkinson disease research.

Journal: Nature reviews. Neurology
Published: January 07, 2026

Exploring immunomodulation with azathioprine in Parkinson's disease.

Exploring immunomodulation with azathioprine in Parkinson's disease.

Journal: The Lancet. Neurology
Published: November 20, 2025

Characterization of motor and non-motor features associated with bilateral nigral degeneration due to A53T alpha-synuclein in female rats.

Characterization of motor and non-motor features associated with bilateral nigral degeneration due to A53T alpha-synuclein in female rats.

Journal: Scientific reports
Published: September 15, 2025
Showing 1-12 of 118

Last Updated: 09/26/2026